Seattle, Washington, United States The venture was found in North America in United States. The main department of described VC is located in the Seattle.
The top activity for fund was in 2016. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in some founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Wellness, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Rodeo Therapeutics, ApoGen Biotechnologies, Magnolia NeuroSciences.
The typical case for the fund is to invest in rounds with 9 participants. The meaningful sponsors for the fund in investment in the same round are Johnson & Johnson Innovation, ARCH Venture Partners, WuXi AppTec. In the next rounds fund is usually obtained by M Ventures.
Related Funds
| Fund Name | Location |
| Allbrook & Company | Minneapolis, Minnesota, United States |
| Citrus Ventures | California, Encino, United States |
| Cork | Japan, Tokyo |
| Dayiwang | Beijing, Beijing, China |
| Estag Capital | Berlin, Berlin, Germany |
| Fearless Ventures | California, San Francisco, United States |
| Hengjin Touzi | - |
| Innovation Norway | Norway, Oslo |
| Liberty Technologies, Inc. | Liberty, Missouri, United States |
| Lockheed Martin | Bethesda, Maryland, United States |
| MAA Group | Kuala Lumpur, Malaysia |
| Merlin Biomed | New York, New York, United States |
| Phunware | Austin, Texas, United States |
| Precursor | California, San Francisco, United States |
| Simulation Ventures | Incline Village, Nevada, United States |
| Tata AIA Life Insurance Company | India, Maharashtra, Mumbai |
| Unity Asset Management | China, Shanghai |
| Vestar Capital Partners | New York, New York, United States |
| Winnipeg Capital | Lima, Lima, Peru |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Proniras Corp | $4M | 01 Feb 2024 | Seattle, Washington, United States | ||
Magnolia NeuroSciences | $31M | 13 Aug 2018 | New York, New York, United States | ||
Rodeo Therapeutics | $5M | 25 Jul 2017 | Seattle, Washington, United States | ||
ApoGen Biotechnologies | $7M | 12 Dec 2016 | Seattle, Washington, United States | ||
Petra Pharma | $48M | 06 Jan 2016 | New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Proniras Corp | $4M | 01 Feb 2024 | Seattle, Washington, United States | ||
Magnolia NeuroSciences | $31M | 13 Aug 2018 | New York, New York, United States | ||
Rodeo Therapeutics | $5M | 25 Jul 2017 | Seattle, Washington, United States | ||
ApoGen Biotechnologies | $7M | 12 Dec 2016 | Seattle, Washington, United States | ||
Petra Pharma | $48M | 06 Jan 2016 | New York, United States |
